Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| LEXICON PHARMACEUTICALS, INC.LXRX · Entity 4970 | EVP, Innov & Chem Sciences | February 28, 2025 | March 03, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
LEXICON PHARMACEUTICALS, INC.
Report date February 28, 2025 · Filed March 03, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 339,104 |
Ending reported balance
After 2025-02-28 transaction · row 4
4 source rows · reconciled sequenceRow 1 · 2025-02-28 · Exercise / conversion · Acquired 25,667 · Balance 281,391 F1: Each restricted stock unit represents a contingent right to receive one share of common stock. Row 2 · 2025-02-28 · Exercise / conversion · Acquired 32,904 · Balance 314,295 F1: Each restricted stock unit represents a contingent right to receive one share of common stock. Row 3 · 2025-02-28 · Exercise / conversion · Acquired 68,243 · Balance 382,538 F1: Each restricted stock unit represents a contingent right to receive one share of common stock. Row 4 · 2025-02-28 · Tax withholding · Disposed 43,434 · Balance 339,104 F2: Withholding of a portion of issued shares by the Company in satisfaction of shareholder's tax withholding obligations with respect thereto. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2025-02-28 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2025-02-28 · Exercise / conversion · Disposed 25,667 · Balance 0 F1: Each restricted stock unit represents a contingent right to receive one share of common stock. F3: Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 32,903 |
Reported balance
After 2025-02-28 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2025-02-28 · Exercise / conversion · Disposed 32,904 · Balance 32,903 F1: Each restricted stock unit represents a contingent right to receive one share of common stock. F3: Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 136,487 |
Reported balance
After 2025-02-28 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2025-02-28 · Exercise / conversion · Disposed 68,243 · Balance 136,487 F1: Each restricted stock unit represents a contingent right to receive one share of common stock. F3: Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. |
Filing footnotes · ownership attribution and instrument terms
F1: Each restricted stock unit represents a contingent right to receive one share of common stock.
F2: Withholding of a portion of issued shares by the Company in satisfaction of shareholder's tax withholding obligations with respect thereto.
F3: Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 28, 2020 Filed Mar 3, 2020 21:13 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Exercise / conversionRestricted Stock Units · Derivative | 8,296 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-20-008956 · form4.xml · derivative · entry 8 MAIN ALAN J · CIK 0001227372 · EVP, Commercial Supply Ops 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,297 Underlying: Common Stock · 8,296 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. F5 · derivative.exercise_date: Restricted stock units vest with respect to one third of the shares subject to the restricted stock units on February 28, 2019 and vest an additional one third on February 28 of each of the two succeeding years thereafter. F5 · derivative.expiration_date: Restricted stock units vest with respect to one third of the shares subject to the restricted stock units on February 28, 2019 and vest an additional one third on February 28 of each of the two succeeding years thereafter. Read SEC document |
| February 28, 2020 Filed Mar 3, 2020 21:13 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Exercise / conversionRestricted Stock Units · Derivative | 2,498 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-20-008956 · form4.xml · derivative · entry 7 MAIN ALAN J · CIK 0001227372 · EVP, Commercial Supply Ops 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,497 Underlying: Common Stock · 2,498 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. F4 · derivative.exercise_date: Restricted stock units vest with respect to 25% of the shares subject to the restricted stock units on February 28, 2018 and vest an additional 25% on February 28 of each of the three succeeding years thereafter. F4 · derivative.expiration_date: Restricted stock units vest with respect to 25% of the shares subject to the restricted stock units on February 28, 2018 and vest an additional 25% on February 28 of each of the three succeeding years thereafter. Read SEC document |
| February 28, 2020 Filed Mar 3, 2020 21:13 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Exercise / conversionRestricted Stock Units · Derivative | 4,085 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-20-008956 · form4.xml · derivative · entry 6 MAIN ALAN J · CIK 0001227372 · EVP, Commercial Supply Ops 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,085 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. F3 · derivative.exercise_date: Restricted stock units vest with respect to 25% of the shares subject to the restricted stock units on February 28, 2017 and vest an additional 25% on February 28 of each of the three succeeding years thereafter. F3 · derivative.expiration_date: Restricted stock units vest with respect to 25% of the shares subject to the restricted stock units on February 28, 2017 and vest an additional 25% on February 28 of each of the three succeeding years thereafter. Read SEC document |
| February 28, 2020 Filed Mar 3, 2020 21:13 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Tax withholdingCommon Stock | 12,759 | $2.77 | $35,342.43 |
DisclosureSEC source: 0001127602-20-008956 · form4.xml · nonDerivative · entry 5 MAIN ALAN J · CIK 0001227372 · EVP, Commercial Supply Ops 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 91,560 F2 · kind: Withholding of a portion of issued shares by the Company in satisfaction of shareholder's tax withholding obligations with respect thereto. Read SEC document |
| February 28, 2020 Filed Mar 3, 2020 21:13 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Exercise / conversionCommon Stock | 22,373 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-20-008956 · form4.xml · nonDerivative · entry 4 MAIN ALAN J · CIK 0001227372 · EVP, Commercial Supply Ops 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 104,319 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. Read SEC document |
| February 28, 2020 Filed Mar 3, 2020 21:13 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Exercise / conversionCommon Stock | 8,296 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-20-008956 · form4.xml · nonDerivative · entry 3 MAIN ALAN J · CIK 0001227372 · EVP, Commercial Supply Ops 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 81,946 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. Read SEC document |
| February 28, 2020 Filed Mar 3, 2020 21:13 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Exercise / conversionCommon Stock | 2,498 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-20-008956 · form4.xml · nonDerivative · entry 2 MAIN ALAN J · CIK 0001227372 · EVP, Commercial Supply Ops 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 73,650 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. Read SEC document |
| February 28, 2020 Filed Mar 3, 2020 21:13 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Exercise / conversionCommon Stock | 4,085 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-20-008956 · form4.xml · nonDerivative · entry 1 MAIN ALAN J · CIK 0001227372 · EVP, Commercial Supply Ops 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 71,152 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. Read SEC document |
| February 06, 2020 Filed Feb 10, 2020 21:13 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | GrantStock Option (Right to Buy) · Derivative | 209,700 | $0.00 Strike: $3.31 | $0.00 |
DisclosureSEC source: 0001127602-20-004599 · form4.xml · derivative · entry 2 MAIN ALAN J · CIK 0001227372 · EVP, Commercial Supply Ops 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 209,700 Underlying: Common Stock · 209,700 shares Expires 2030-02-06 F3 · derivative.exercise_date: Option vests with respect to 25% of the shares subject to the option on the first anniversary of grant, and vests 1/48th per month for each month of service thereafter. Read SEC document |
| February 06, 2020 Filed Feb 10, 2020 21:13 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | GrantRestricted Stock Units · Derivative | 69,900 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-004599 · form4.xml · derivative · entry 1 MAIN ALAN J · CIK 0001227372 · EVP, Commercial Supply Ops 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,900 Underlying: Common Stock · 69,900 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. F2 · derivative.exercise_date: Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. F2 · derivative.expiration_date: Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. Read SEC document |
| February 28, 2019 Filed Mar 1, 2019 22:17 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Exercise / conversionRestricted Stock Units · Derivative | 8,297 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-19-009262 · form4.xml · derivative · entry 9 MAIN ALAN J · CIK 0001227372 · EVP, Commercial Supply Ops 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,593 Underlying: Common Stock · 8,297 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. F6 · derivative.exercise_date: Restricted stock units vest with respect to one third of the shares subject to the restricted stock units on February 28, 2019 and vest an additional one third on February 28 of each of the two succeeding years thereafter. F6 · derivative.expiration_date: Restricted stock units vest with respect to one third of the shares subject to the restricted stock units on February 28, 2019 and vest an additional one third on February 28 of each of the two succeeding years thereafter. Read SEC document |
| February 28, 2019 Filed Mar 1, 2019 22:17 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Exercise / conversionRestricted Stock Units · Derivative | 2,498 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-19-009262 · form4.xml · derivative · entry 8 MAIN ALAN J · CIK 0001227372 · EVP, Commercial Supply Ops 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,995 Underlying: Common Stock · 2,498 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. F5 · derivative.exercise_date: Restricted stock units vest with respect to 25% of the shares subject to the restricted stock units on February 28, 2018 and vest an additional 25% on February 28 of each of the three succeeding years thereafter. F5 · derivative.expiration_date: Restricted stock units vest with respect to 25% of the shares subject to the restricted stock units on February 28, 2018 and vest an additional 25% on February 28 of each of the three succeeding years thereafter. Read SEC document |
| February 28, 2019 Filed Mar 1, 2019 22:17 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Exercise / conversionRestricted Stock Units · Derivative | 4,085 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-19-009262 · form4.xml · derivative · entry 7 MAIN ALAN J · CIK 0001227372 · EVP, Commercial Supply Ops 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,085 Underlying: Common Stock · 4,085 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. F4 · derivative.exercise_date: Restricted stock units vest with respect to 25% of the shares subject to the restricted stock units on February 28, 2017 and vest an additional 25% on February 28 of each of the three succeeding years thereafter. F4 · derivative.expiration_date: Restricted stock units vest with respect to 25% of the shares subject to the restricted stock units on February 28, 2017 and vest an additional 25% on February 28 of each of the three succeeding years thereafter. Read SEC document |
| February 28, 2019 Filed Mar 1, 2019 22:17 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Exercise / conversionRestricted Stock Units · Derivative | 5,271 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-19-009262 · form4.xml · derivative · entry 6 MAIN ALAN J · CIK 0001227372 · EVP, Commercial Supply Ops 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,271 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. F3 · derivative.exercise_date: Restricted stock units vest with respect to 25% of the shares subject to the restricted stock units on February 28, 2016 and vest an additional 25% on February 28 of each of the three succeeding years thereafter. F3 · derivative.expiration_date: Restricted stock units vest with respect to 25% of the shares subject to the restricted stock units on February 28, 2016 and vest an additional 25% on February 28 of each of the three succeeding years thereafter. Read SEC document |
| February 28, 2019 Filed Mar 1, 2019 22:17 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Tax withholdingCommon Stock | 6,885 | $5.51 | $37,936.35 |
DisclosureSEC source: 0001127602-19-009262 · form4.xml · nonDerivative · entry 5 MAIN ALAN J · CIK 0001227372 · EVP, Commercial Supply Ops 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,067 F2 · kind: Withholding of a portion of vested shares by the Company in satisfaction of shareholder's tax withholding obligations with respect thereto. Read SEC document |
| February 28, 2019 Filed Mar 1, 2019 22:17 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Exercise / conversionCommon Stock | 8,297 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-19-009262 · form4.xml · nonDerivative · entry 4 MAIN ALAN J · CIK 0001227372 · EVP, Commercial Supply Ops 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 73,952 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. Read SEC document |
| February 28, 2019 Filed Mar 1, 2019 22:17 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Exercise / conversionCommon Stock | 2,498 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-19-009262 · form4.xml · nonDerivative · entry 3 MAIN ALAN J · CIK 0001227372 · EVP, Commercial Supply Ops 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,655 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. Read SEC document |
| February 28, 2019 Filed Mar 1, 2019 22:17 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Exercise / conversionCommon Stock | 4,085 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-19-009262 · form4.xml · nonDerivative · entry 2 MAIN ALAN J · CIK 0001227372 · EVP, Commercial Supply Ops 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,157 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. Read SEC document |
| February 28, 2019 Filed Mar 1, 2019 22:17 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Exercise / conversionCommon Stock | 5,271 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-19-009262 · form4.xml · nonDerivative · entry 1 MAIN ALAN J · CIK 0001227372 · EVP, Commercial Supply Ops 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,072 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. Read SEC document |
| February 07, 2019 Filed Feb 8, 2019 23:07 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | GrantRestricted Stock Units · Derivative | 67,120 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-004882 · form4.xml · derivative · entry 2 MAIN ALAN J · CIK 0001227372 · EVP, Commercial Supply Ops 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,120 Underlying: Common Stock · 67,120 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. F3 · derivative.exercise_date: Restricted stock units vest with respect to one third of the shares subject to the restricted stock units on February 28, 2020 and vest an additional one third on February 28 of each of the two succeeding years thereafter. F3 · derivative.expiration_date: Restricted stock units vest with respect to one third of the shares subject to the restricted stock units on February 28, 2020 and vest an additional one third on February 28 of each of the two succeeding years thereafter. Read SEC document |
| February 07, 2019 Filed Feb 8, 2019 23:07 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | GrantStock Option (Right to Buy) · Derivative | 124,640 | $0.00 Strike: $5.16 | $0.00 |
DisclosureSEC source: 0001127602-19-004882 · form4.xml · derivative · entry 1 MAIN ALAN J · CIK 0001227372 · EVP, Commercial Supply Ops 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 124,640 Underlying: Common Stock · 124,640 shares Expires 2029-02-07 F1 · derivative.exercise_date: Option vests with respect to 25% of the shares subject to the option on the first anniversary of grant (2/7/2020) and vests 1/48th per month for each month of service thereafter Read SEC document |
| February 28, 2018 Filed Mar 2, 2018 22:08 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Exercise / conversionRestricted Stock Units · Derivative | 2,497 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-18-009729 · form4.xml · derivative · entry 9 MAIN ALAN J · CIK 0001227372 · EVP, Commercial Supply Ops 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,493 Underlying: Common Stock · 2,497 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. F6 · derivative.exercise_date: Restricted stock units vest with respect to 25% of the shares subject to the restricted stock units on February 28, 2018 and vest an additional 25% on February 28 of each of the three succeeding years thereafter. F6 · derivative.expiration_date: Restricted stock units vest with respect to 25% of the shares subject to the restricted stock units on February 28, 2018 and vest an additional 25% on February 28 of each of the three succeeding years thereafter. Read SEC document |
| February 28, 2018 Filed Mar 2, 2018 22:08 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Exercise / conversionRestricted Stock Units · Derivative | 4,085 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-18-009729 · form4.xml · derivative · entry 8 MAIN ALAN J · CIK 0001227372 · EVP, Commercial Supply Ops 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,170 Underlying: Common Stock · 4,085 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. F5 · derivative.exercise_date: Restricted stock units vest with respect to 25% of the shares subject to the restricted stock units on February 28, 2017 and vest an additional 25% on February 28 of each of the three succeeding years thereafter. F5 · derivative.expiration_date: Restricted stock units vest with respect to 25% of the shares subject to the restricted stock units on February 28, 2017 and vest an additional 25% on February 28 of each of the three succeeding years thereafter. Read SEC document |
| February 28, 2018 Filed Mar 2, 2018 22:08 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Exercise / conversionRestricted Stock Units · Derivative | 5,272 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-18-009729 · form4.xml · derivative · entry 7 MAIN ALAN J · CIK 0001227372 · EVP, Commercial Supply Ops 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,271 Underlying: Common Stock · 5,272 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. F4 · derivative.exercise_date: Restricted stock units vest with respect to 25% of the shares subject to the restricted stock units on February 28, 2016 and vest an additional 25% on February 28 of each of the three succeeding years thereafter. F4 · derivative.expiration_date: Restricted stock units vest with respect to 25% of the shares subject to the restricted stock units on February 28, 2016 and vest an additional 25% on February 28 of each of the three succeeding years thereafter. Read SEC document |
| February 28, 2018 Filed Mar 2, 2018 22:08 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Exercise / conversionRestricted Stock Units · Derivative | 2,679 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-18-009729 · form4.xml · derivative · entry 6 MAIN ALAN J · CIK 0001227372 · EVP, Commercial Supply Ops 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,679 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. F3 · derivative.exercise_date: Restricted stock units vest with respect to 25% of the shares subject to the restricted stock units on February 28, 2015 and vest an additional 25% on February 28 of each of the three succeeding years thereafter. F3 · derivative.expiration_date: Restricted stock units vest with respect to 25% of the shares subject to the restricted stock units on February 28, 2015 and vest an additional 25% on February 28 of each of the three succeeding years thereafter. Read SEC document |
| February 28, 2018 Filed Mar 2, 2018 22:08 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Tax withholdingCommon Stock | 4,962 | $8.53 | $42,325.86 |
DisclosureSEC source: 0001127602-18-009729 · form4.xml · nonDerivative · entry 5 MAIN ALAN J · CIK 0001227372 · EVP, Commercial Supply Ops 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,801 F2 · kind: Withholding of a portion of issued shares by the Company in satisfaction of shareholder's tax withholding obligations with respect thereto. Read SEC document |
| February 28, 2018 Filed Mar 2, 2018 22:08 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Exercise / conversionCommon Stock | 2,497 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-18-009729 · form4.xml · nonDerivative · entry 4 MAIN ALAN J · CIK 0001227372 · EVP, Commercial Supply Ops 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,763 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. Read SEC document |
| February 28, 2018 Filed Mar 2, 2018 22:08 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Exercise / conversionCommon Stock | 4,085 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-18-009729 · form4.xml · nonDerivative · entry 3 MAIN ALAN J · CIK 0001227372 · EVP, Commercial Supply Ops 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,266 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. Read SEC document |
| February 28, 2018 Filed Mar 2, 2018 22:08 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Exercise / conversionCommon Stock | 5,272 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-18-009729 · form4.xml · nonDerivative · entry 2 MAIN ALAN J · CIK 0001227372 · EVP, Commercial Supply Ops 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,181 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. Read SEC document |
| February 28, 2018 Filed Mar 2, 2018 22:08 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Exercise / conversionCommon Stock | 2,679 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-18-009729 · form4.xml · nonDerivative · entry 1 MAIN ALAN J · CIK 0001227372 · EVP, Commercial Supply Ops 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,909 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. Read SEC document |
| February 08, 2018 Filed Feb 12, 2018 22:13 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | GrantStock Option (Right to Buy) · Derivative | 69,940 | $0.00 Strike: $9.79 | $0.00 |
DisclosureSEC source: 0001127602-18-005202 · form4.xml · derivative · entry 2 MAIN ALAN J · CIK 0001227372 · EVP, Commercial Supply Ops 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,940 Underlying: Common Stock · 69,940 shares Expires 2028-02-08 F3 · derivative.exercise_date: Option vests with respect to 25% of the shares subject to the option on the first anniversary of grant (2/8/2019) and vests 1/48th per month for each month of service thereafter. Read SEC document |
| February 08, 2018 Filed Feb 12, 2018 22:13 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | GrantRestricted Stock Units · Derivative | 24,890 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-18-005202 · form4.xml · derivative · entry 1 MAIN ALAN J · CIK 0001227372 · EVP, Commercial Supply Ops 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,890 Underlying: Common Stock · 24,890 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. F2 · derivative.exercise_date: Restricted stock units vest with respect to one third of the shares subject to the restricted stock units on February 28, 2019 and vest an additional one third on February 28 of each of the two succeeding years thereafter. F2 · derivative.expiration_date: Restricted stock units vest with respect to one third of the shares subject to the restricted stock units on February 28, 2019 and vest an additional one third on February 28 of each of the two succeeding years thereafter. Read SEC document |
| February 28, 2017 Filed Mar 1, 2017 23:50 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Exercise / conversionRestricted Stock Units (Phantom Stock) · Derivative | 4,085 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-17-009395 · form4.xml · derivative · entry 9 MAIN ALAN J · CIK 0001227372 · EVP, CMC and Supply Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,255 Underlying: Common Stock · 4,085 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. F6 · derivative.exercise_date: Restricted stock units vest with respect to 25% of the shares subject to the restricted stock units on February 28, 2017 and vest an additional 25% on February 28 of each of the three succeeding years thereafter. F6 · derivative.expiration_date: Restricted stock units vest with respect to 25% of the shares subject to the restricted stock units on February 28, 2017 and vest an additional 25% on February 28 of each of the three succeeding years thereafter. Read SEC document |
| February 28, 2017 Filed Mar 1, 2017 23:50 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Exercise / conversionRestricted Stock Units (Phantom Stock) · Derivative | 5,271 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-17-009395 · form4.xml · derivative · entry 8 MAIN ALAN J · CIK 0001227372 · EVP, CMC and Supply Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,543 Underlying: Common Stock · 5,271 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. F5 · derivative.exercise_date: Restricted stock units vest with respect to 25% of the shares subject to the restricted stock units on February 28, 2016 and vest an additional 25% on February 28 of each of the three succeeding years thereafter. F5 · derivative.expiration_date: Restricted stock units vest with respect to 25% of the shares subject to the restricted stock units on February 28, 2016 and vest an additional 25% on February 28 of each of the three succeeding years thereafter. Read SEC document |
| February 28, 2017 Filed Mar 1, 2017 23:50 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Exercise / conversionRestricted Stock Units (Phantom Stock) · Derivative | 2,678 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-17-009395 · form4.xml · derivative · entry 7 MAIN ALAN J · CIK 0001227372 · EVP, CMC and Supply Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,679 Underlying: Common Stock · 2,678 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. F4 · derivative.exercise_date: Restricted stock units vest with respect to 25% of the shares subject to the restricted stock units on February 28, 2015 and vest an additional 25% on February 28 of each of the three succeeding years thereafter. F4 · derivative.expiration_date: Restricted stock units vest with respect to 25% of the shares subject to the restricted stock units on February 28, 2015 and vest an additional 25% on February 28 of each of the three succeeding years thereafter. Read SEC document |
| February 28, 2017 Filed Mar 1, 2017 23:50 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Exercise / conversionRestricted Stock Units (Phantom Stock) · Derivative | 2,357 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-17-009395 · form4.xml · derivative · entry 6 MAIN ALAN J · CIK 0001227372 · EVP, CMC and Supply Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,357 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. F3 · derivative.exercise_date: Restricted stock units vest with respect to 25% of the shares subject to the restricted stock units on February 28, 2014 and vest an additional 25% on February 28 of each of the three succeeding years thereafter. F3 · derivative.expiration_date: Restricted stock units vest with respect to 25% of the shares subject to the restricted stock units on February 28, 2014 and vest an additional 25% on February 28 of each of the three succeeding years thereafter. Read SEC document |
| February 28, 2017 Filed Mar 1, 2017 23:50 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Tax withholdingCommon Stock | 5,361 | $16.45 | $88,188.45 |
DisclosureSEC source: 0001127602-17-009395 · form4.xml · nonDerivative · entry 5 MAIN ALAN J · CIK 0001227372 · EVP, CMC and Supply Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,230 F2 · kind: Withholding of a portion of issued shares by the Company in satisfaction of shareholder's tax withholding obligations with respect thereto. Read SEC document |
| February 28, 2017 Filed Mar 1, 2017 23:50 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Exercise / conversionCommon Stock | 4,085 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-17-009395 · form4.xml · nonDerivative · entry 4 MAIN ALAN J · CIK 0001227372 · EVP, CMC and Supply Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,591 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. Read SEC document |
| February 28, 2017 Filed Mar 1, 2017 23:50 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Exercise / conversionCommon Stock | 5,271 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-17-009395 · form4.xml · nonDerivative · entry 3 MAIN ALAN J · CIK 0001227372 · EVP, CMC and Supply Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,506 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. Read SEC document |
| February 28, 2017 Filed Mar 1, 2017 23:50 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Exercise / conversionCommon Stock | 2,678 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-17-009395 · form4.xml · nonDerivative · entry 2 MAIN ALAN J · CIK 0001227372 · EVP, CMC and Supply Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,235 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. Read SEC document |
| February 28, 2017 Filed Mar 1, 2017 23:50 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Exercise / conversionCommon Stock | 2,357 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-17-009395 · form4.xml · nonDerivative · entry 1 MAIN ALAN J · CIK 0001227372 · EVP, CMC and Supply Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,557 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. Read SEC document |
| February 09, 2017 Filed Feb 13, 2017 21:26 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | GrantRestricted Stock Units (Phantom Stock) · Derivative | 9,990 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-005424 · form4.xml · derivative · entry 2 MAIN ALAN J · CIK 0001227372 · EVP, CMC and Supply Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,990 Underlying: Common Stock · 9,990 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. F3 · derivative.exercise_date: Restricted stock units vest with respect to 25% of the shares subject to the restricted stock units on February 28, 2018 and vest an additional 25% on February 28 of each of the three succeeding years thereafter. F3 · derivative.expiration_date: Restricted stock units vest with respect to 25% of the shares subject to the restricted stock units on February 28, 2018 and vest an additional 25% on February 28 of each of the three succeeding years thereafter. Read SEC document |
| February 09, 2017 Filed Feb 13, 2017 21:26 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | GrantStock Option (Right to Buy) · Derivative | 39,960 | $0.00 Strike: $14.44 | $0.00 |
DisclosureSEC source: 0001127602-17-005424 · form4.xml · derivative · entry 1 MAIN ALAN J · CIK 0001227372 · EVP, CMC and Supply Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,960 Underlying: Common Stock · 39,960 shares Expires 2027-02-09 F1 · derivative.exercise_date: Option vests with respect to 25% of the shares subject to the option on the first anniversary of grant (2/9/2018) and vests 1/48th per month for each month of service thereafter Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.